Krishana Phoschem profit and loss

·UnclassifiedChart ›

Latest FY26

Revenue: ₹2,418cr+78.0% on FY25
EBITDA: ₹298cr+62.2% on FY25
Net profit: ₹180cr+108.2% on FY25
EPS: ₹29.14+108.1% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	2,555	2,418	1,358	924	323	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	19.2	15.8	9.9	0.9	2.9
	2,574	2,434	1,368	925	326
	1,272	1,175	786	583	155
	864	692	110	86.1	57.1
	−287	−128	12.6	−53.2	−3.6
	48.4	44.1	27.7	17.5	13.7
	50.1	38.7	39.5	36.8	6.8
	40.5	34.4	31.2	34.2	8.7
	335	336	238	161	49.4
	2,324	2,193	1,245	866	287
	322	298	184	129	51.6
	281	264	153	94.9	42.9
Profit
	250	241	123	59.1	38.9
	250	241	123	59.1	38.9
	48.0	42.2	21.6	10.5	7.1
	5.7	18.7	15.1	8.1	5.1
	53.7	60.9	36.7	18.6	12.2
	197	180	86.5	40.4	26.7
	197	180	86.5	40.4	26.7
	−0.2	−0.1	−0.2	−0.1	−0.1
	196	180	86.3	40.3	26.7
Per share
	₹25.71	₹29.14	₹14.00	₹6.54	₹8.80
	₹25.71	₹29.14	₹14.00	₹6.54	₹8.65
Other comprehensive income — detail
	—	−0.1	−0.2	—	—
	—	−0.2	—	—	−0.1
	—	−0.0	0.3	—	—
	—	—	—	0.2	−0.0
	—	—	−0.1	—	—
	—	—	—	−0.0	0.0
Per share — as-filed variants
	₹25.71	₹29.14	₹14.00	₹6.54	₹8.80
	₹25.71	₹29.14	₹14.00	₹6.54	₹8.65
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	705	679	449	308	115
	27.6%	28.1%	33.1%	33.3%	35.5%
Adjusted (ex-exceptional items) — derived
	250	241	123	59.1	38.9
	197	180	86.5	40.4	26.7
	₹25.71	₹29.14	₹14.00	₹6.54	₹8.80

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

KRISHANA₹222.63

Krishana Phoschem Limited

· Unclassified

Annual Quarterly₹ CrorePeersICEMAKE IRISDOREME MMP SWARAJ MBAPL GKWLIMITEDKRISHNADEFMcap ₹1,376 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	322.8	923.9	1,358.2	2,418.0	2,554.8
Other Income	2.9	0.9	9.9	15.8	19.2
Total Income	325.7	924.8	1,368.2	2,433.8	2,574.0
Expenses
+ Cost of Materials Consumed	154.6	583.0	786.2	1,175.2	1,272.1
+ Purchases of Stock-in-Trade	57.1	86.1	110.3	692.0	864.4
+ Changes in Inventories	-3.6	-53.2	12.6	-128.0	-286.8
+ Employee Benefit Expense	13.7	17.5	27.7	44.1	48.4
+ Finance Costs	6.8	36.8	39.5	38.7	50.1
+ Depreciation & Amortisation	8.7	34.2	31.2	34.4	40.5
+ Other Expenses	49.4	161.4	237.5	336.4	335.0
Total Expenses	286.8	865.8	1,244.9	2,192.8	2,323.6
EBITDA	51.6	129.0	184.0	298.3	321.7
EBIT	42.9	94.9	152.8	263.9	281.3
Profit
PBT before Exceptional Items	38.9	59.1	123.3	241.0	250.4
Pretax Income	38.9	59.1	123.3	241.0	250.4
+ Current Tax	7.1	10.5	21.6	42.2	48.0
+ Deferred Tax	5.1	8.1	15.1	18.7	5.7
Tax Expense	12.2	18.6	36.7	60.9	53.7
Net Income	26.7	40.4	86.5	180.1	196.7
+ Net Income — Continuing Ops	26.7	40.4	86.5	180.1	196.7
+ Other Comprehensive Income	-0.1	-0.1	-0.2	-0.1	-0.2
Total Comprehensive Income	26.7	40.3	86.3	180.0	196.5
Per Share
Basic EPS	8.80	6.54	14.00	29.14	25.71
Diluted EPS	8.65	6.54	14.00	29.14	25.71
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	-0.2	-0.1	—
+ Items NOT to be Reclassified to P&L	-0.1	—	—	-0.2	—
+ Tax on Items NOT to be Reclassified	—	—	0.3	-0.0	—
+ Tax on Items NOT to be Reclassified — alt tag	-0.0	0.2	—	—	—
+ Tax on Items to be Reclassified	—	—	-0.1	—	—
+ Tax on Items to be Reclassified — alt tag	0.0	-0.0	—	—	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	8.80	6.54	14.00	29.14	25.71
Diluted EPS — Continuing Operations	8.65	6.54	14.00	29.14	25.71
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	114.6	307.9	449.2	678.8	705.1
Gross Margin %	35.51	33.33	33.07	28.07	27.60
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	38.9	59.1	123.3	241.0	250.4
Net Income Adj (tax-effected)	26.7	40.4	86.5	180.1	196.7
EPS Adj	8.80	6.54	14.00	29.14	25.71
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	2.00
Paid Up Equity Capital	30.9	61.8	61.8	61.8	61.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.